— Synthetic Biology and Bio, Pillars of Japan's Growth Strategy — Gathering of Next-Generation Technologies for Decarbonization and Industrial Competitiveness

RX Japan Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Executive Officer and President: Takeshi Tanaka) will host "INTERPHEX Week Tokyo / Regenerative Medicine EXPO Tokyo" for three days from May 20 (Wednesday) to 22 (Friday), 2026, at Makuhari Messe. In recent years, the government has positioned the bioeconomy as a core of "new capitalism" and is accelerating investment in the bio-manufacturing sector, including synthetic biology. Additionally, from the perspective of GX (Green Transformation), there is a growing shift from conventional petroleum-derived processes to bio-derived ones, and biotechnology is attracting attention as a key to achieving both decarbonization and industrial competitiveness. Furthermore, amidst increasing uncertainties surrounding the supply chains of pharmaceuticals and raw materials, the establishment of manufacturing bases and domestic repatriation in the bio sector are gaining importance from the perspective of economic security. The viewpoint of "how to stably manufacture and supply," not just research and development, is becoming a factor that will determine future industrial competitiveness. Against this backdrop, this exhibition will bring together companies and research institutions at the forefront of bio-manufacturing, including synthetic biology, biopharmaceuticals, and contract development and manufacturing organizations (CDMOs). ■ Bio x Manufacturing: Pioneering the Next-Generation Industrial Structure In this field, advances in biotechnology are driving a shift towards an industrial structure that integrates "research" with "manufacturing" and "supply." The venue will feature companies in the R&D domain such as Takara Bio Inc. and LIVIUS JAPAN Co., Ltd., manufacturing process technologies from Asahi Kasei Life Science Corporation, and companies responsible for supply and infrastructure such as Kaneka Corporation and Eppendorf AG. This allows for an overview of the next-generation industrial structure, encompassing not only the "research and development" of biopharmaceuticals and regenerative medicine but also the perspective of "how to stably manufacture and deliver." ■ Exhibited Products and Services This exhibition will bring together technologies supporting each area of the bio-industry: "Research & Development," "Manufacturing," and "Supply & Infrastructure." 【Research & Development Area】 GMP Manufacturing of Cell-Based Products We provide various cell-based product manufacturing services based on proven technology from the development of gene-modified T lymphocyte therapies such as TCR (T cell receptor) gene therapy and CAR (chimeric antigen receptor) gene therapy, and clinical trial achievements. We also possess various know-how using Takara Bio's gene transfer enhancer RetroNectin, with multiple achievements in closed-system cell culture. [Exhibitor: Takara Bio Inc.] Hair Growth Reagent Applying Proprietary miRNA Technology to Improve Follicle Cell Environment This is a hair growth reagent that applies proprietary miRNA technology to improve the follicle cell environment. It approaches the hair cycle from the perspective of activating cell function, pursuing a mechanism of action different from existing treatments. An application example of cell function improvement technology in the field of regenerative medicine. [Exhibitor: LIVIUS JAPAN Co., Ltd.] 【Manufacturing & Process Area】 Virus Removal Related Equipment We are committed to solving challenges in the safety, efficiency, and purity of therapeutic drugs in the pharmaceutical and bioprocess industries. Utilizing technology platforms such as oligonucleotide synthesis, inline buffer preparation, chromatography, and bioprocess filtration, we develop state-of-the-art and precisely manufactured equipment that brings innovation to the future of pharmaceutical manufacturing, together with our customers. [Exhibitor: Asahi Kasei Life Science Corporation] 【Supply & Infrastructure Area】 Environmentally Friendly Sustainable "BioBased" Consumables (Tips, Tubes, Plates) These are environmentally friendly "BioBased" consumables made from sustainable raw materials produced from edible oil residues, reducing the use of fossil fuels. Using these contributes to sustainability. The lineup includes pipette tips, tubes, and PCR plates. [Exhibitor: Eppendorf AG] Constant Temperature Transport Package "TACPack®" TACPack® is a constant temperature transport package that can maintain a constant temperature for a long time by combining phase change materials like "Passamo" with insulation containers designed and manufactured in-house. In addition, products are exhibited by temperature range (-65℃ to +37℃) and application (domestic, international, etc.). [Exhibitor: Kaneka Corporation] ■ Event Overview INTERPHEX Week Tokyo / Regenerative Medicine EXPO Tokyo ・Dates: May 20 (Wednesday) - 22 (Friday), 2026, 10:00 - 17:00 ・Venue: Makuhari Messe Halls 1-8 ・Organizer: RX Japan Co., Ltd. ・INTERPHEX Week Constituent Exhibitions: INTERPHEX Japan / in-Pharma Japan / Bio-Pharmaceutical EXPO / PharmaLab EXPO / Pharma DX